The release way back on 28/10/2021 mentions a USA 2022 EuGeni Entry. Though we now know the Sepsis project has been scaled to longer timeliness.
"In preparation for a US market entry with the EuGeni Reader, COVID-19 RAT, FluA/ FluB COVID-19 Multiplex and Sepsis in 2022, AnteoTech has appointed a US-based market entry and marketing consultant. These specialists have previously consulted with major companies, including Ellume, to navigate the US point of care and healthcare sectors successfully. The newly appointed Head of Product & Services, Pierre Nathie, will be working closely with our consultant, preparing the go-tomarket strategy, and identifying US-based distribution partners and agents. Entry into the US market is predicated on the successful registration of the products with the US Food and Drug Administration (FDA)."
- Forums
- ASX - By Stock
- ADO
- EuGeni
EuGeni, page-2326
-
-
- There are more pages in this discussion • 340 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ADO (ASX) to my watchlist
|
|||||
Last
2.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $51.83M |
Open | High | Low | Value | Volume |
2.1¢ | 2.2¢ | 2.1¢ | $3.414K | 161.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 384663 | 2.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.2¢ | 616353 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 384663 | 0.021 |
12 | 2157550 | 0.020 |
10 | 3040767 | 0.019 |
10 | 1652665 | 0.018 |
4 | 194160 | 0.017 |
Price($) | Vol. | No. |
---|---|---|
0.022 | 616353 | 6 |
0.023 | 857853 | 5 |
0.024 | 1306228 | 3 |
0.025 | 254144 | 5 |
0.027 | 680612 | 2 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
ADO (ASX) Chart |